Browse EV MemProt Atlas
Supporting publications (n)
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
EVMP confidence score
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| PE2R4 | P35408 | Prostaglandin E2 receptor EP4 subtype (PGE receptor EP4 subtype) (PGE2 receptor EP4 subtype) (Prostanoid EP4 receptor) | 7 | AbortionArterial occlusive diseaseCoronary atherosclerosis | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 2 | 0.25 | |||
| QSOX2 | Q6ZRP7 | Sulfhydryl oxidase 2 (EC 1.8.3.2) (Neuroblastoma-derived sulfhydryl oxidase) (Quiescin Q6-like protein 1) | EnzymesPredicted intracellular proteinsPredicted membrane proteins | 1 | Other mediation | 2 | 0.25 | |||
| S12A6 | Q9UHW9 | Solute carrier family 12 member 6 (Electroneutral potassium-chloride cotransporter 3) (K-Cl cotransporter 3) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.25 | |||
| S15A2 | Q16348 | Solute carrier family 15 member 2 (Kidney H(+)/peptide cotransporter) (Oligopeptide transporter, kidney isoform) (Peptide transporter 2) | 12 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.25 | ||||
| S19A2 | O60779 | Thiamine transporter 1 (ThTr-1) (ThTr1) (Solute carrier family 19 member 2) (Thiamine carrier 1) (TC1) | Disease related genesHuman disease related genesMetabolic proteins | 12 | Fusion and delivery mediationMetabolism mediation | 2 | 0.25 | |||
| S1PR2 | O95136 | Sphingosine 1-phosphate receptor 2 (S1P receptor 2) (S1P2) (Endothelial differentiation G-protein coupled receptor 5) (Sphingosine 1-phosphate receptor Edg-5) (S1P receptor Edg-5) | Disease related genesG-protein coupled receptorsHuman disease related genes | 7 | Ulcerative colitis | Clinical-translation mediationReceptor-signaling mediation | 2 | 0.25 | ||
| S1PR3 | Q99500 | Sphingosine 1-phosphate receptor 3 (S1P receptor 3) (S1P3) (Endothelial differentiation G-protein coupled receptor 3) (Sphingosine 1-phosphate receptor Edg-3) (S1P receptor Edg-3) | 7 | Breast cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 2 | 0.25 | |||
| S29A1 | Q99808 | Equilibrative nucleoside transporter 1 (hENT1) (Equilibrative nitrobenzylmercaptopurine riboside-sensitive nucleoside transporter) (Equilibrative NBMPR-sensitive nucleoside transporter) (es nucleoside transporter) (Nucleoside transporter, es-type) (Solute carrier family 29 member 1) | Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteins | 11 | Angina pectoris | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.25 | ||
| S6A11 | P48066 | Sodium- and chloride-dependent GABA transporter 3 (GAT-3) (Solute carrier family 6 member 11) | Metabolic proteinsPredicted membrane proteinsTransporters | 12 | Indeterminate colitis | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.25 | ||
| SC6A8 | P48029 | Sodium- and chloride-dependent creatine transporter 1 (CT1) (Creatine transporter 1) (Solute carrier family 6 member 8) | 12 | Malignant digestive organ neoplasm | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.25 | |||
| SEM4F | O95754 | Semaphorin-4F (Semaphorin-M) (Sema M) (Semaphorin-W) (Sema W) | Predicted intracellular proteinsPredicted membrane proteins | 1 | Receptor-signaling mediation | 2 | 0.25 | |||
| SEM4G | Q9NTN9 | Semaphorin-4G | Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins | 1 | Receptor-signaling mediation | 2 | 0.25 | |||
| SGCB | Q16585 | Beta-sarcoglycan (Beta-SG) (43 kDa dystrophin-associated glycoprotein) (43DAG) (A3b) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Muscular dystrophy | Clinical-translation mediationFusion and delivery mediationMetabolism mediation | 2 | 0.25 | ||
| SGCD | Q92629 | Delta-sarcoglycan (Delta-SG) (35 kDa dystrophin-associated glycoprotein) (35DAG) | 1 | Metabolism mediationReceptor-signaling mediation | 2 | 0.25 | ||||
| SIDT2 | Q8NBJ9 | SID1 transmembrane family member 2 | Predicted intracellular proteinsPredicted membrane proteinsTransporters | 10 | Fusion and delivery mediationMetabolism mediation | 2 | 0.25 | |||
| SL9A7 | Q96T83 | Sodium/hydrogen exchanger 7 (Na(+)/H(+) exchanger 7) (NHE-7) (Solute carrier family 9 member 7) | Disease related genesHuman disease related genesMetabolic proteins | 14 | Clinical-translation mediationFusion and delivery mediation | 2 | 0.25 | |||
| T106B | Q9NUM4 | Transmembrane protein 106B | Disease related genesHuman disease related genesPotential drug targets | 1 | Fusion and delivery mediation | 2 | 0.25 | |||
| TM63C | Q9P1W3 | Osmosensitive cation channel TMEM63C (Calcium permeable stress-gated cation channel 1) (Transmembrane protein 63C) (hTMEM63C) | Disease related genesHuman disease related genesPotential drug targets | 11 | Other mediation | 2 | 0.25 | |||
| TSN1 | O60635 | Tetraspanin-1 (Tspan-1) (Tetraspan NET-1) (Tetraspanin TM4-C) | Predicted membrane proteins | 4 | Fusion and delivery mediation | 2 | 0.25 | |||
| TTYH3 | Q9C0H2 | Protein tweety homolog 3 (hTTY3) (Volume-regulated anion channel subunit TTYH3) | Predicted membrane proteinsTransporters | 5 | Fusion and delivery mediation | 2 | 0.25 | |||
| 5HT1D | P28221 | 5-hydroxytryptamine receptor 1D (5-HT-1D) (5-HT1D) (Serotonin 1D alpha receptor) (5-HT-1D-alpha) (Serotonin receptor 1D) | 7 | Alzheimer diseaseDementiaDepression | Clinical-translation mediationReceptor-signaling mediation | 1 | 0.25 | |||
| ABCA5 | Q8WWZ7 | Cholesterol transporter ABCA5 (EC 7.6.2.-) (ATP-binding cassette sub-family A member 5) | Human disease related genesPredicted intracellular proteinsPredicted membrane proteins | 15 | Fusion and delivery mediation | 1 | 0.25 | |||
| ADA17 | P78536 | Disintegrin and metalloproteinase domain-containing protein 17 (ADAM 17) (EC 3.4.24.86) (Snake venom-like protease) (TNF-alpha convertase) (TNF-alpha-converting enzyme) (CD antigen CD156b) | CD markersDisease related genesEnzymes | 1 | Breast cancerChronic obstructive pulmonary diseaseIndeterminate colitis | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 1 | 0.25 | ||
| ADA2A | P08913 | Alpha-2A adrenergic receptor (Alpha-2 adrenergic receptor subtype C10) (Alpha-2A adrenoreceptor) (Alpha-2A adrenoceptor) (Alpha-2AAR) | 7 | Alzheimer diseaseAttention deficit hyperactivity disorderDementia | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 | |||
| AGTR1 | P30556 | Type-1 angiotensin II receptor (AT1AR) (AT1BR) (Angiotensin II type-1 receptor) (AT1 receptor) | Disease related genesFDA approved drug targetsG-protein coupled receptors | 7 | Alzheimer diseaseArteries/arterioles disorderEssential hypertension | Clinical-translation mediationFusion and delivery mediationImmune mediation | 1 | 0.25 |